Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3689931015 | Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3689933017 | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
53214301000001115 | Dalfopristin 350mg / Quinupristin 150mg powder for solution for infusion vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
60257201000001110 | Quinupristin 150mg / Dalfopristin 350mg powder for solution for infusion vials | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing dalfopristin and quinupristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Quinupristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Dalfopristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance | Dalfopristin | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator value | 350 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has precise active ingredient | Dalfopristin mesilate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has precise active ingredient | Quinupristin mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance | Quinupristin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing only dalfopristin and quinupristin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Dalfopristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Is a | Quinupristin + Dalfopristin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Quinupristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intravenous route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninfusion.intravenous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Quinupristin mesilate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Dalfopristin mesilate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Dalfopristin mesilate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Quinupristin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Dalfopristin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has specific active ingredient | Dalfopristin mesilate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has specific active ingredient | Quinupristin mesilate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has dispensed dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance | Quinupristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance | Dalfopristin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Has dispensed dose form | Powder for conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Quinupristin+dalfopristin 150mg/350mg infusion (pdr for recon) - product | Is a | False | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Inferred relationship | Existential restriction modifier | |
Synercid powder for solution for injection vials (Aventis Pharma) | Is a | True | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Inferred relationship | Existential restriction modifier | |
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial | Is pack of | False | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Inferred relationship | Existential restriction modifier | |
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial | Has VMP | True | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets